BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38629299)

  • 1. The impact of SOX4-activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma.
    Ai C; Huang Z; Rong T; Shen W; Yang F; Li Q; Bi L; Li W
    Electrophoresis; 2024 Apr; ():. PubMed ID: 38629299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3.
    Wang T; Zhu X; Wang K; Li J; Hu X; Lin P; Zhang J
    Pulm Pharmacol Ther; 2023 Jun; 80():102217. PubMed ID: 37121465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells.
    Li Y; Huang HQ; Huang ZH; Yu ND; Ye XL; Jiang MC; Chen LM
    Diagn Pathol; 2023 Mar; 18(1):33. PubMed ID: 36864456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of CTHRC1 by HOXB9 Promotes Angiogenesis through Fatty Acid Metabolism in Lung Adenocarcinoma.
    Liu K; Li X; Yang Z; Zhang R
    Rev Invest Clin; 2022; 75(2):63-75. PubMed ID: 37205792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor E2F8 activates PDK1-mediated DNA damage repair to enhance cisplatin resistance in lung adenocarcinoma.
    Li H; Sun J; Hu H; Wang Y
    Pharmacology; 2024 May; ():. PubMed ID: 38810606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma.
    Gong L; Xiao M; He D; Hu Y; Zhu Y; Xiang L; Bao Y; Liu X; Zeng Q; Liu J; Zhou M; Zhou Y; Cheng Y; Zhang Y; Deng L; Zhu R; Lan H; Cao K
    Front Oncol; 2020; 10():461. PubMed ID: 32426268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis.
    Liu Y; Zhai R; Hu S; Liu J
    Anticancer Drugs; 2022 Jan; 33(1):e186-e197. PubMed ID: 34387608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TFAP2A Upregulates SKA3 to Promote Glycolysis and Reduce the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin.
    Liu G; Liu X; Zeng W; Zhou W
    Pharmacology; 2024 Apr; ():1-14. PubMed ID: 38643755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTHRC1 targeted by miR-30a-5p regulates cell adhesion, invasion and migration in lung adenocarcinoma.
    Yang C; Huang T; Liang Y; Xue Y; Liang Y; Wei X; Meng F; Wei Q
    J Cardiothorac Surg; 2022 Mar; 17(1):46. PubMed ID: 35313900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway.
    Shi W; Ling L; Li C; Wu R; Zhang M; Shao F; Wang Y
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1295-1311. PubMed ID: 35792913
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wang Z; Zhou L; Chen B; Li X; Zou Q; Xu W; Fang L; Wu A; Li Z; Chen Y
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of SOX4 on DDP Resistance in Non-small Cell Lung Cancer Cell of A549].
    Li W; Liu X; Zhang G; Zhang L
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):298-302. PubMed ID: 28532536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.
    Hu B; Zhang H; Wang Z; Zhang F; Wei H; Li L
    Cancer Biol Ther; 2017 Dec; 18(12):974-983. PubMed ID: 29020498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Let-7c-5p Represses Cisplatin Resistance of Lung Adenocarcinoma Cells by Targeting CDC25A.
    Huang L; Lou K; Wang K; Liang L; Chen Y; Zhang J
    Appl Biochem Biotechnol; 2023 Mar; 195(3):1644-1655. PubMed ID: 36355336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-133a-3p Inhibits Lung Adenocarcinoma Development and Cisplatin Resistance through Targeting GINS4.
    Zhou Y; Yan J; Chen H; Zhou W; Yang J
    Cells Tissues Organs; 2024; 213(1):55-66. PubMed ID: 36273455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa-miR-503-5p regulates CTDSPL to accelerate cisplatin resistance and angiogenesis of lung adenocarcinoma cells.
    Han J; Wang Y
    Chem Biol Drug Des; 2023 Oct; 102(4):749-762. PubMed ID: 37341065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-SOX4 drives the tumorigenesis and development of lung adenocarcinoma via sponging miR-1270 and modulating PLAGL2 to activate WNT signaling pathway.
    Gao N; Ye B
    Cancer Cell Int; 2020; 20():2. PubMed ID: 31911754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway.
    Tang W; Yu X; Zeng R; Chen L
    Cancer Manag Res; 2020; 12():2001-2014. PubMed ID: 32256108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation.
    Gong L; Hu Y; He D; Zhu Y; Xiang L; Xiao M; Bao Y; Liu X; Zeng Q; Liu J; Zhou M; Zhou Y; Cheng Y; Zhang Y; Deng L; Zhu R; Lan H; Cao K
    Cancer Cell Int; 2020; 20():194. PubMed ID: 32508530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.